Morgellons disease is a controversial and poorly defined symptom cluster of skin lesions and somatic symptoms, most notably ‘fibers’ in the skin. Because of widespread coverage in the media and on the Internet, there are an increasing number of patients presenting to dermatologists. We present three patients who believed that they had fibers in their skin. We offer a discussion of delusions of parasitosis to demonstrate similarities between these conditions. It has been suggested by a limited number of healthcare providers that an unknown infectious agent underlies this symptom complex yet no available evidence supports this assertion. Laboratory values that would be reflective of an infectious process (e.g. elevated white blood cells, sedimentation rate, C reactive protein) are routinely normal and biopsies often reflect only nonspecific findings such as acute and chronic inflammation with erosion or ulceration.
Patients with Morgellons disease generally lack insight into their disease and reject the need for psychiatric help. The goal is to build trust and refrain from minimizing what the patient experiences. Attentive examination of the patient’s skin and fragments they present is necessary to rule out a true underlying pathologic process and to establish a trusting relationship. A supportive, non-confrontational approach is ideal. The patient is best treated by a team of practitioners of several specialties, including dermatologists, psychiatrists, and counselors.
No sources of funding were used to prepare this article. The authors have no conflicts of interest that are directly relevant to the content of this article.
Zomer SF, De Wit RF, Van Bronswijk JE, et al. Delusions of parasitosis: a psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol 1998; 138: 1030–2PubMedCrossRefGoogle Scholar
Szepietowski JC, Salomon J, Hrehorow E, et al. Delusional parasitosis in dermatological practice. J Eur Acad Dermatol Venereol 2007; 21: 462–5PubMedGoogle Scholar
Koo J, Lee CS. Delusions of parasitosis: a dermatologist’s guide to diagnosis and treatment. Am J Clin Dermatol 2001; 2: 285–90PubMedCrossRefGoogle Scholar
Lee CS. Delusions of parasitosis. Dermatol Ther 2008 Jan-Feb; 21 (1): 2–7Google Scholar
Rathbone J, McMonagle T. Pimozide for schizophrenia or related psychoses. Cochrane Database Syst Rev 2007 Jul 18; (3): 1–102Google Scholar
Lorenzo CR, Koo J. Pimozide in dermatologic practice: a comprehensive review. Am J Clin Dermatol 2004; 5: 339–49PubMedCrossRefGoogle Scholar
Mauri MCVL, Colasanti A, Fiorentini A, et al. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinet 2007; 46 (5): 359–88PubMedCrossRefGoogle Scholar
Freudenmann RW, Schonfeldt-Lecuona C, Lepping P. Primary delusional parasitosis treated with olanzapine. Int Psychogeriatr 2007; 19: 1161–8PubMedCrossRefGoogle Scholar
Meehan WJ, Badreshia S, Mackley CL. Successful treatment of delusions of parasitosis with olanzapine. Arch Dermatol 2006; 142: 352–5PubMedCrossRefGoogle Scholar
Lepping P, Russell I, Freudenmann RW. Antipsychotic treatment of primary delusional parasitosis: systematic review. Br J Psychiatry 2007; 191: 198–205PubMedCrossRefGoogle Scholar
Wenning MT, Davy LE, Catalano G, et al. Atypical antipsychotics in the treatment of delusional parasitosis. Ann Clin Psychiatry 2003; 15: 233–9PubMedGoogle Scholar
Mercan S, Altunay IK, Taskintuna N, et al. Atypical antipsychotic drugs in the treatment of delusional parasitosis. Int J Psychiatry Med 2007; 37: 29–37PubMedCrossRefGoogle Scholar
Walling HW, Swick BL. Psychocutaneous syndromes: a call for revised nomenclature. Clin Exp Dermatol 2007; 32: 317–9PubMedCrossRefGoogle Scholar